As research continues to advance, the future of a-synuclein PET imaging looks more promising than ever before, with the potential to revolutionize early diagnosis, therapeutic monitoring, and personalized treatment strategies for synucleinopathies, as well as the entire neurodegenerative disease field. Here, SNCA is linked to synucleinopathy.